Industry sponsorship and research outcome

A Lundh, J Lexchin, B Mintzes… - … of systematic reviews, 2017 - cochranelibrary.com
Background Clinical research affecting how doctors practice medicine is increasingly
sponsored by companies that make drugs and medical devices. Previous systematic …

Cognitive therapy for depression

J Scott - British Medical Bulletin, 2001 - academic.oup.com
There is considerable empirical support for the use of cognitive therapy in the treatment of
mild to moderately severe acute major depression. More recent research has focused on the …

[HTML][HTML] Dose equivalents of antidepressants: evidence-based recommendations from randomized controlled trials

Y Hayasaka, M Purgato, LR Magni, Y Ogawa… - Journal of affective …, 2015 - Elsevier
Background Dose equivalence of antidepressants is critically important for clinical practice
and for research. There are several methods to define and calculate dose equivalence but …

An integrated model to assess and treat compulsive sexual behaviour disorder

P Briken - Nature Reviews Urology, 2020 - nature.com
Contrary to common belief, hypersexual or compulsive sexual behaviour disorder is not a
current fashion diagnosis. Nevertheless, the introduction of dedicated diagnostic guidelines …

Herb-anticancer drug interactions in real life based on VigiBase, the WHO global database

S Pochet, AS Lechon, C Lescrainier, C De Vriese… - Scientific reports, 2022 - nature.com
Cancer patients could combine herbal treatments with their chemotherapy. We consulted
VigiBase, a WHO database of individual case safety reports (ICSRs) which archives reports …

Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults

TL McCloud, C Caddy, J Jochim… - Cochrane Database …, 2015 - cochranelibrary.com
Background There is emerging evidence that glutamatergic system dysfunction might play
an important role in the pathophysiology of bipolar depression. This review focuses on the …

Incidence of adverse events and comparative tolerability of selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for the …

NP Gosmann, M de Abreu Costa… - Psychological …, 2023 - cambridge.org
Selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake
inhibitors (SNRIs) show similar efficacy as treatments for anxiety, obsessive-compulsive, and …

Pharmacokinetic pharmacogenetic prescribing guidelines for antidepressants: a template for psychiatric precision medicine

M Nassan, WT Nicholson, MA Elliott, CRR Vitek… - Mayo Clinic …, 2016 - Elsevier
Antidepressants are commonly prescribed medications in the United States, and there is
increasing interest in individualizing treatment selection for more than 20 US Food and Drug …

[HTML][HTML] Application of intranasal administration in the delivery of antidepressant active ingredients

Z **, Y Han, D Zhang, Z Li, Y **g, B Hu, S Sun - Pharmaceutics, 2022 - mdpi.com
As a mental disease in modern society, depression shows an increasing occurrence, with
low cure rate and high recurrence rate. It has become the most disabling disease in the …

Depression in primary care: part 2—management

P Ramanuj, EK Ferenchick, HA Pincus - BMJ, 2019 - bmj.com
Depression is a common and heterogeneous condition with a chronic and recurrent natural
course that is frequently seen in the primary care setting. Primary care providers play a …